Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Pregabalin add-on for drug-resistant focal epilepsy.

Panebianco M, Bresnahan R, Hemming K, Marson AG.

Cochrane Database Syst Rev. 2019 Jul 9;7:CD005612. doi: 10.1002/14651858.CD005612.pub4. [Epub ahead of print] Review.

PMID:
31287157
2.
3.

Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Nevitt SJ, Sudell M, Tudur Smith C, Marson AG.

Cochrane Database Syst Rev. 2019 Jun 24;6:CD012065. doi: 10.1002/14651858.CD012065.pub3. Review.

PMID:
31233229
4.

Protocol for the development of a core outcome set for cauda equina syndrome: systematic literature review, qualitative interviews, Delphi survey and consensus meeting.

Srikandarajah N, Noble AJ, Wilby M, Clark S, Williamson PR, Marson AG.

BMJ Open. 2019 May 1;9(4):e024002. doi: 10.1136/bmjopen-2018-024002.

5.

Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy.

Walker LE, Frigerio F, Ravizza T, Ricci E, Tse K, Jenkins RE, Sills GJ, Jorgensen A, Porcu L, Thippeswamy T, Alapirtti T, Peltola J, Brodie MJ, Park BK, Marson AG, Antoine DJ, Vezzani A, Pirmohamed M.

J Clin Invest. 2019 Apr 8;130:2166. doi: 10.1172/JCI129285. eCollection 2019 Apr 8. No abstract available.

6.

Brivaracetam add-on therapy for drug-resistant epilepsy.

Bresnahan R, Panebianco M, Marson AG.

Cochrane Database Syst Rev. 2019 Mar 28;3:CD011501. doi: 10.1002/14651858.CD011501.pub2.

PMID:
30920649
7.

Identifying patients who will not reachieve remission after breakthrough seizures.

Hughes DM, Bonnett LJ, Marson AG, García-Fiñana M.

Epilepsia. 2019 Apr;60(4):774-782. doi: 10.1111/epi.14697. Epub 2019 Mar 22.

PMID:
30900756
8.

A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine.

Berghuis B, Stapleton C, Sonsma ACM, Hulst J, de Haan GJ, Lindhout D, Demurtas R; EpiPGX Consortium, Krause R, Depondt C, Kunz WS, Zara F, Striano P, Craig J, Auce P, Marson AG, Stefansson H, O'Brien TJ, Johnson MR, Sills GJ, Wolking S, Lerche H, Sisodiya SM, Sander JW, Cavalleri GL, Koeleman BPC, McCormack M.

Epilepsia Open. 2019 Jan 17;4(1):102-109. doi: 10.1002/epi4.12297. eCollection 2019 Mar.

9.

Resting-state functional brain networks in adults with a new diagnosis of focal epilepsy.

Alonazi BK, Keller SS, Fallon N, Adams V, Das K, Marson AG, Sluming V.

Brain Behav. 2019 Jan;9(1):e01168. doi: 10.1002/brb3.1168. Epub 2018 Nov 28.

10.

Identification of patients who will not achieve seizure remission within 5 years on AEDs.

Hughes DM, Bonnett LJ, Czanner G, Komárek A, Marson AG, García-Fiñana M.

Neurology. 2018 Nov 27;91(22):e2035-e2044. doi: 10.1212/WNL.0000000000006564. Epub 2018 Nov 2.

11.

Gabapentin add-on treatment for drug-resistant focal epilepsy.

Panebianco M, Al-Bachari S, Weston J, Hutton JL, Marson AG.

Cochrane Database Syst Rev. 2018 Oct 24;10:CD001415. doi: 10.1002/14651858.CD001415.pub3.

PMID:
30357813
12.

Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.

Nevitt SJ, Marson AG, Tudur Smith C.

Cochrane Database Syst Rev. 2018 Oct 24;10:CD001904. doi: 10.1002/14651858.CD001904.pub4.

PMID:
30353945
13.

Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.

Nevitt SJ, Tudur Smith C, Marson AG.

Cochrane Database Syst Rev. 2018 Oct 23;10:CD003615. doi: 10.1002/14651858.CD003615.pub4.

PMID:
30350354
14.

Pharmacological management of post-traumatic seizures in adults: current practice patterns in the UK and the Republic of Ireland.

Mee H, Kolias AG, Chari A, Ercole A, Lecky F, Turner C, Tudur-Smith C, Coles J, Anwar F, Belli A, Manford M, Ham T, McMahon C, Bulters D, Uff C, Duncan JS, Wilson MH, Marson AG, Hutchinson PJ.

Acta Neurochir (Wien). 2019 Mar;161(3):457-464. doi: 10.1007/s00701-018-3683-9. Epub 2018 Oct 1.

15.

Neuroradiological findings in patients with "non-lesional" focal epilepsy revealed by research protocol.

Kreilkamp BAK, Das K, Wieshmann UC, Biswas S, Marson AG, Keller SS.

Clin Radiol. 2019 Jan;74(1):78.e1-78.e11. doi: 10.1016/j.crad.2018.08.013. Epub 2018 Sep 28.

16.

A Caenorhabditis elegans assay of seizure-like activity optimised for identifying antiepileptic drugs and their mechanisms of action.

Wong SQ, Jones A, Dodd S, Grimes D, Barclay JW, Marson AG, Cunliffe VT, Burgoyne RD, Sills GJ, Morgan A.

J Neurosci Methods. 2018 Nov 1;309:132-142. doi: 10.1016/j.jneumeth.2018.09.004. Epub 2018 Sep 3.

17.

Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.

Nevitt SJ, Marson AG, Weston J, Tudur Smith C.

Cochrane Database Syst Rev. 2018 Aug 9;8:CD001769. doi: 10.1002/14651858.CD001769.pub4.

PMID:
30091458
18.

Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study.

May P, Girard S, Harrer M, Bobbili DR, Schubert J, Wolking S, Becker F, Lachance-Touchette P, Meloche C, Gravel M, Niturad CE, Knaus J, De Kovel C, Toliat M, Polvi A, Iacomino M, Guerrero-López R, Baulac S, Marini C, Thiele H, Altmüller J, Jabbari K, Ruppert AK, Jurkowski W, Lal D, Rusconi R, Cestèle S, Terragni B, Coombs ID, Reid CA, Striano P, Caglayan H, Siren A, Everett K, Møller RS, Hjalgrim H, Muhle H, Helbig I, Kunz WS, Weber YG, Weckhuysen S, Jonghe P, Sisodiya SM, Nabbout R, Franceschetti S, Coppola A, Vari MS, Kasteleijn-Nolst Trenité D, Baykan B, Ozbek U, Bebek N, Klein KM, Rosenow F, Nguyen DK, Dubeau F, Carmant L, Lortie A, Desbiens R, Clément JF, Cieuta-Walti C, Sills GJ, Auce P, Francis B, Johnson MR, Marson AG, Berghuis B, Sander JW, Avbersek A, McCormack M, Cavalleri GL, Delanty N, Depondt C, Krenn M, Zimprich F, Peter S, Nikanorova M, Kraaij R, van Rooij J, Balling R, Ikram MA, Uitterlinden AG, Avanzini G, Schorge S, Petrou S, Mantegazza M, Sander T, LeGuern E, Serratosa JM, Koeleman BPC, Palotie A, Lehesjoki AE, Nothnagel M, Nürnberg P, Maljevic S, Zara F, Cossette P, Krause R, Lerche H; Epicure Consortium; EuroEPINOMICS CoGIE Consortium; EpiPGX Consortium.

Lancet Neurol. 2018 Aug;17(8):699-708. doi: 10.1016/S1474-4422(18)30215-1. Epub 2018 Jul 17.

19.

Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Nevitt SJ, Tudur Smith C, Weston J, Marson AG.

Cochrane Database Syst Rev. 2018 Jun 28;6:CD001031. doi: 10.1002/14651858.CD001031.pub4. Review.

20.

Antiepileptic drugs as prophylaxis for postcraniotomy seizures.

Greenhalgh J, Weston J, Dundar Y, Nevitt SJ, Marson AG.

Cochrane Database Syst Rev. 2018 May 23;5:CD007286. doi: 10.1002/14651858.CD007286.pub4. Review.

21.

Rufinamide add-on therapy for refractory epilepsy.

Panebianco M, Prabhakar H, Marson AG.

Cochrane Database Syst Rev. 2018 Apr 25;4:CD011772. doi: 10.1002/14651858.CD011772.pub2. Review.

22.

The Modified Ketogenic Diet in Adults with Glioblastoma: An Evaluation of Feasibility and Deliverability within the National Health Service.

Martin-McGill KJ, Marson AG, Tudur Smith C, Jenkinson MD.

Nutr Cancer. 2018 May-Jun;70(4):643-649. doi: 10.1080/01635581.2018.1460677. Epub 2018 Apr 18.

PMID:
29668317
23.

The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: a systematic review.

Martin-McGill KJ, Srikandarajah N, Marson AG, Tudur Smith C, Jenkinson MD.

CNS Oncol. 2018 Apr;7(2):CNS17. doi: 10.2217/cns-2017-0030. Epub 2018 Apr 16.

24.

A voxel-based asymmetry study of the relationship between hemispheric asymmetry and language dominance in Wada tested patients.

Keller SS, Roberts N, Baker G, Sluming V, Cezayirli E, Mayes A, Eldridge P, Marson AG, Wieshmann UC.

Hum Brain Mapp. 2018 Jul;39(7):3032-3045. doi: 10.1002/hbm.24058. Epub 2018 Mar 23.

25.

Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.

McCormack M, Gui H, Ingason A, Speed D, Wright GEB, Zhang EJ, Secolin R, Yasuda C, Kwok M, Wolking S, Becker F, Rau S, Avbersek A, Heggeli K, Leu C, Depondt C, Sills GJ, Marson AG, Auce P, Brodie MJ, Francis B, Johnson MR, Koeleman BPC, Striano P, Coppola A, Zara F, Kunz WS, Sander JW, Lerche H, Klein KM, Weckhuysen S, Krenn M, Gudmundsson LJ, Stefánsson K, Krause R, Shear N, Ross CJD, Delanty N; EPIGEN Consortium;, Pirmohamed M, Carleton BC; Canadian Pharmacogenomics Network for Drug Safety;, Cendes F, Lopes-Cendes I, Liao WP, O'Brien TJ, Sisodiya SM; EpiPGX Consortium;, Cherny S, Kwan P, Baum L; International League Against Epilepsy Consortium on Complex Epilepsies;, Cavalleri GL.

Neurology. 2018 Jan 23;90(4):e332-e341. doi: 10.1212/WNL.0000000000004853. Epub 2017 Dec 29. Erratum in: Neurology. 2018 Oct 16;91(16):765.

26.

Breakthrough seizures-Further analysis of the Standard versus New Antiepileptic Drugs (SANAD) study.

Bonnett LJ, Powell GA, Tudur Smith C, Marson AG.

PLoS One. 2017 Dec 21;12(12):e0190035. doi: 10.1371/journal.pone.0190035. eCollection 2017.

27.

Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

Nevitt SJ, Sudell M, Weston J, Tudur Smith C, Marson AG.

Cochrane Database Syst Rev. 2017 Dec 15;12:CD011412. doi: 10.1002/14651858.CD011412.pub3. Review.

28.

Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study.

Martin-McGill KJ, Marson AG, Tudur Smith C, Jenkinson MD.

Pilot Feasibility Stud. 2017 Nov 28;3:67. doi: 10.1186/s40814-017-0209-9. eCollection 2017.

29.

Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children.

Bromley RL, Weston J, Marson AG.

JAMA. 2017 Nov 7;318(17):1700-1701. doi: 10.1001/jama.2017.14485.

PMID:
29114815
30.

The modified ketogenic diet for adults with refractory epilepsy: An evaluation of a set up service.

Martin-McGill KJ, Jenkinson MD, Tudur Smith C, Marson AG.

Seizure. 2017 Nov;52:1-6. doi: 10.1016/j.seizure.2017.08.013. Epub 2017 Sep 1.

31.

Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.

Androsova G, Krause R, Borghei M, Wassenaar M, Auce P, Avbersek A, Becker F, Berghuis B, Campbell E, Coppola A, Francis B, Wolking S, Cavalleri GL, Craig J, Delanty N, Koeleman BPC, Kunz WS, Lerche H, Marson AG, Sander JW, Sills GJ, Striano P, Zara F, Sisodiya SM, Depondt C; EpiPGX Consortium.

Epilepsia. 2017 Oct;58(10):1734-1741. doi: 10.1111/epi.13871. Epub 2017 Aug 31.

32.

Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access.

Powell GA, Bonnett LJ, Tudur-Smith C, Hughes DA, Williamson PR, Marson AG.

Trials. 2017 Aug 23;18(1):389. doi: 10.1186/s13063-017-2135-9. Review.

33.

Deep brain and cortical stimulation for epilepsy.

Sprengers M, Vonck K, Carrette E, Marson AG, Boon P.

Cochrane Database Syst Rev. 2017 Jul 18;7:CD008497. doi: 10.1002/14651858.CD008497.pub3. Review.

34.
35.

Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

Nevitt SJ, Sudell M, Weston J, Tudur Smith C, Marson AG.

Cochrane Database Syst Rev. 2017 Jun 29;6:CD011412. doi: 10.1002/14651858.CD011412.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Dec 15;12 :CD011412.

36.

Epilepsy and Pregnancy: For healthy pregnancies and happy outcomes. Suggestions for service improvements from the Multispecialty UK Epilepsy Mortality Group.

Leach JP, Smith PE, Craig J, Bagary M, Cavanagh D, Duncan S, Kelso ARC, Marson AG, McCorry D, Nashef L, Nelson-Piercy C, Northridge R, Sieradzan K, Thangaratinam S, Walker M, Winterbottom J, Reuber M.

Seizure. 2017 Aug;50:67-72. doi: 10.1016/j.seizure.2017.05.004. Epub 2017 Jun 1. Review.

37.

Epilepsy management in older people: Lessons from National Audit of Seizure management in Hospitals (NASH).

Ziso B, Dixon PA, Marson AG.

Seizure. 2017 Aug;50:33-37. doi: 10.1016/j.seizure.2017.05.002. Epub 2017 May 30.

38.

Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from Epoxide Metabolites of Carbamazepine in Patients.

Yip VLM, Meng X, Maggs JL, Jenkins RE, Marlot PT, Marson AG, Park BK, Pirmohamed M.

Chem Res Toxicol. 2017 Jul 17;30(7):1419-1435. doi: 10.1021/acs.chemrestox.7b00063. Epub 2017 Jun 12.

PMID:
28562019
39.

Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy.

Walker LE, Frigerio F, Ravizza T, Ricci E, Tse K, Jenkins RE, Sills GJ, Jorgensen A, Porcu L, Thippeswamy T, Alapirtti T, Peltola J, Brodie MJ, Park BK, Marson AG, Antoine DJ, Vezzani A, Pirmohamed M.

J Clin Invest. 2017 Jun 1;127(6):2118-2132. doi: 10.1172/JCI92001. Epub 2017 May 15. Retraction in: J Clin Invest. 2019 Apr 8;130:2166.

40.

Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis.

Lamberink HJ, Otte WM, Geerts AT, Pavlovic M, Ramos-Lizana J, Marson AG, Overweg J, Sauma L, Specchio LM, Tennison M, Cardoso TMO, Shinnar S, Schmidt D, Geleijns K, Braun KPJ.

Lancet Neurol. 2017 Jul;16(7):523-531. doi: 10.1016/S1474-4422(17)30114-X. Epub 2017 May 5. Review. Erratum in: Lancet Neurol. 2017 Aug;16(8):584.

PMID:
28483337
41.

Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review.

Nevitt SJ, Marson AG, Davie B, Reynolds S, Williams L, Smith CT.

BMJ. 2017 Apr 5;357:j1390. doi: 10.1136/bmj.j1390. Review.

42.

Genetic regulation of gene expression in the epileptic human hippocampus.

Mirza N, Appleton R, Burn S, du Plessis D, Duncan R, Farah JO, Feenstra B, Hviid A, Josan V, Mohanraj R, Shukralla A, Sills GJ, Marson AG, Pirmohamed M.

Hum Mol Genet. 2017 May 1;26(9):1759-1769. doi: 10.1093/hmg/ddx061.

43.

A disease, disorder, illness or condition: How to label epilepsy?

Noble AJ, Robinson A, Marson AG.

Acta Neurol Scand. 2017 Nov;136(5):536-540. doi: 10.1111/ane.12757. Epub 2017 Mar 14.

44.

Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.

Nevitt SJ, Marson AG, Weston J, Tudur Smith C.

Cochrane Database Syst Rev. 2017 Feb 27;2:CD001911. doi: 10.1002/14651858.CD001911.pub3. Review.

45.

Developing and assessing the acceptability of an epilepsy first aid training intervention for patients who visit UK emergency departments: A multi-method study of patients and professionals.

Snape DA, Morgan M, Ridsdale L, Goodacre S, Marson AG, Noble AJ.

Epilepsy Behav. 2017 Mar;68:177-185. doi: 10.1016/j.yebeh.2017.01.006. Epub 2017 Feb 16.

46.

'Epileptic', 'epileptic person' or 'person with epilepsy'? Bringing quantitative and qualitative evidence on the views of UK patients and carers to the terminology debate.

Noble AJ, Robinson A, Snape D, Marson AG.

Epilepsy Behav. 2017 Feb;67:20-27. doi: 10.1016/j.yebeh.2016.10.034. Epub 2017 Jan 11.

47.

Paramedics' views on their seizure management learning needs: a qualitative study in England.

Sherratt FC, Snape D, Goodacre S, Jackson M, Pearson M, Marson AG, Noble AJ.

BMJ Open. 2017 Jan 9;7(1):e014024. doi: 10.1136/bmjopen-2016-014024.

48.

Identifying new antiepileptic drugs through genomics-based drug repurposing.

Mirza N, Sills GJ, Pirmohamed M, Marson AG.

Hum Mol Genet. 2017 Feb 1;26(3):527-537. doi: 10.1093/hmg/ddw410.

PMID:
28053048
49.

Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.

Nolan SJ, Marson AG, Weston J, Tudur Smith C.

Cochrane Database Syst Rev. 2016 Dec 15;12:CD001904. doi: 10.1002/14651858.CD001904.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Oct 24;10:CD001904.

50.

Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.

Powell G, Saunders M, Rigby A, Marson AG.

Cochrane Database Syst Rev. 2016 Dec 8;12:CD007124. doi: 10.1002/14651858.CD007124.pub5. Review.

Supplemental Content

Loading ...
Support Center